Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.
about
Current and potential treatments for ubiquitous but neglected herpesvirus infectionsMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaPhosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic SignalingHyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential.A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteinsAmino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2.Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP.Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.Key motifs in EBV (Epstein-Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization.The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliProtein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.Conserved herpesvirus protein kinases.Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsProtein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screeningEpstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production.Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.Expression and localization of the Epstein-Barr virus-encoded protein kinase.Interactome mapping: using protein microarray technology to reconstruct diverse protein networks.Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication.Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.Interindividual Spread of Herpesviruses.The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionSimian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replicationA rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1.Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.The Epstein-Barr virus polymerase accessory factor BMRF1 adopts a ring-shaped structure as visualized by electron microscopy.SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes.
P2860
Q27023452-3AA00BAE-9C59-4AE7-89D0-CE11351B8365Q28472086-226A481D-24BB-46E7-A5FF-7CA7D0502275Q28551996-8BBDD63C-41CC-426A-961E-5ACDE6849F28Q33754919-D37F38DF-7EF7-4A21-A46C-17949C39261DQ33826641-7A2DCFA6-CA18-41E0-AB65-273668D722ECQ33963979-168E054B-AF6D-47B8-A286-1C0FD9BE2E0FQ34105467-43933432-3610-49BC-9C26-ACD9DE58A614Q35024349-55345034-06AE-46ED-893B-DB78AD074A24Q35103227-67014CC6-9FE3-43AC-8AE7-3E0301FCD05DQ35204267-1D05463F-C03D-4D07-84DA-0063C6D8D630Q35635192-045E30CF-2F8A-443B-96AC-6351570D02D7Q35857562-09D9D837-CACC-462C-8330-28504EA1A551Q36399836-326F7655-3AD4-423F-B569-EF6E05EA686BQ36414572-A080CF5A-3221-4798-9F00-9C9FD5D5346FQ36442795-7FCC6907-66D1-4EA7-9F34-409B1929C151Q36491044-0831032E-C0A3-4BD5-8A11-B7123AAB04AAQ36594113-40C2E02A-BC01-4082-A60E-0A5387AD0D65Q37123188-D0951DD6-9142-4E3F-9C23-EEB480FE6B50Q37192108-85BEF26D-6EFD-4970-B22D-BE246CB9EAABQ37278489-E0758A61-1E64-4A6C-B491-A741D41DA60EQ37372076-9648635A-AD57-4717-BE68-27D454EEC381Q37410869-E90C29C1-9E1D-4FEC-BEE5-04D4301AFDF2Q37478310-B62E881C-C27A-4878-8833-3734AE2EC5A4Q37596917-C723E1A7-597C-45E3-80CC-C93785410CC7Q37671058-3F1B217D-8D26-41C1-ADE8-73C2C3DF2008Q37734377-2811A8CB-4EE1-4ADC-8124-AD45325012E3Q39187112-214E1A61-BE17-4A1A-A2A2-20E3A8E55870Q39320366-78653EF1-29DB-4868-8C93-91CBDD5AACB1Q39735571-507D582F-FABE-49C7-8ED4-B244ECD306E6Q39741182-3DD1C118-E12F-45C2-A36A-E8C9FA963BA8Q39798789-E592891E-08E4-42CF-AF5D-25DEE798D2F3Q40125731-ABC7656F-376F-4F7A-88FD-B4FA0DF2F2ACQ40155828-7E3E9391-0793-4215-87F6-93F1E77220BBQ40280193-C4655284-136C-4429-BC39-F624C630098DQ40454370-76F2A420-0102-4AB0-8E31-E0871C23F835Q40529959-1F3A039F-501E-4955-ADEF-31027B5E825EQ41983297-55D77311-6016-4B01-B5CD-6FD461EA68A0Q44713676-99D2CA75-0F13-4FFC-8B20-ECE131F098CB
P2860
Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Phosphorylation of the Epstein ...... iboside benzimidazole 1263W94.
@en
Phosphorylation of the Epstein-Barr virus
@nl
type
label
Phosphorylation of the Epstein ...... iboside benzimidazole 1263W94.
@en
Phosphorylation of the Epstein-Barr virus
@nl
prefLabel
Phosphorylation of the Epstein ...... iboside benzimidazole 1263W94.
@en
Phosphorylation of the Epstein-Barr virus
@nl
P2860
P1433
P1476
Phosphorylation of the Epstein ...... iboside benzimidazole 1263W94.
@en
P2093
Edward Gershburg
Joseph S Pagano
P2860
P304
P356
10.1128/JVI.76.3.998-1003.2002
P407
P577
2002-02-01T00:00:00Z